GenXAI Analytics IPO Day 4: GMP ₹10

Well, here we are, folks, on Day 4 of the GenXAI Analytics SME IPO. The clock is ticking, with the subscription window set to close on June 9th. As of today, the subscription numbers are showing a rather interesting, and perhaps concerning, picture. With the issue price set at ₹110 and a lot size of 1200 shares, many were expecting to see some significant movement by now. Let’s dive into the details and see what this means for potential investors.

Subscription Status

Currently, the subscription figures across all categories are standing at a flat 0x. That’s right, zero. This means that as of Day 4, there have been no applications received from Retail Individual Investors (RIIs), High Networth Individuals (HNIs) or Non-Institutional Investors (NIIs), Qualified Institutional Buyers (QIBs), or even the overall market. This is quite unusual, especially for an SME IPO that has a defined period for subscription. Typically, by Day 4, we’d expect to see at least some traction, even if it’s just a few bids. The complete absence of applications across the board is something that investors will be closely watching. It could indicate a lack of investor interest, or perhaps investors are waiting for the very last moment to apply. However, a zero subscription across all segments at this stage is definitely a point of concern and warrants a closer look at other indicators.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). The current GMP for GenXAI Analytics stands at ₹10. Interestingly, this GMP remained unchanged from yesterday’s ₹10. The expected listing price, based on this GMP and the issue price of ₹110, hovers around ₹120. A GMP of ₹10 suggests a modest listing gain of roughly 9% (₹10 on a ₹110 issue price). While any gain is welcome, a GMP of this magnitude, especially when combined with the zero subscription, doesn’t exactly paint a picture of overwhelming demand. Yesterday’s GMP also being ₹10 suggests that the market sentiment hasn’t seen much of a shift. This could be interpreted in a couple of ways: either the market is cautiously optimistic, or there’s simply not enough buzz to drive the GMP higher. The fact that it hasn’t dipped is a small silver lining, but the lack of upward movement is notable.

Should You Apply?

So, the big question: should you apply for the GenXAI Analytics IPO? It’s a tough call right now, given the data. On one hand, the GMP suggests a potential listing gain, albeit a modest one. On the other hand, the complete lack of subscription on Day 4 is a red flag that can’t be ignored. This could mean that investors are skeptical about the company’s prospects, or perhaps they’re waiting for a clearer signal. SEBI’s advisory is always to do your own research, and that’s more crucial than ever here. You’ll want to thoroughly understand GenXAI Analytics’ business model, financials, and future growth prospects before making any decision. The low GMP coupled with zero subscription means that the risk appetite for this IPO is currently quite low. If you’re a risk-averse investor, you might want to sit this one out and wait for more clarity, or observe the final day’s subscription figures. For those who are comfortable with higher risk and believe in the long-term potential of the company, a small application might be considered, but with extreme caution. Remember, the IPO period ends on June 9th, so there’s still time for things to change, but the current trend is certainly one to monitor very closely.

View Full GenXAI Analytics IPO Details